12753080|t|Pathogenic A beta induces the expression and activation of matrix metalloproteinase-2 in human cerebrovascular smooth muscle cells.
12753080|a|Cerebral amyloid angiopathy (CAA) is a major pathological feature of Alzheimer's disease and related disorders. Human cerebrovascular smooth muscle (HCSM) cells, which are intimately associated with CAA, have been used as an in vitro model system to investigate pathologic interactions with amyloid beta protein (A beta). Previously we have shown that pathogenic forms of A beta induce several pathologic responses in HCSM cells including fibril assembly at the cell surface, increase in the levels of A beta precursor, and apoptotic cell death. Here we show that pathogenic A beta stimulates the expression and activation of matrix metalloproteinase-2 (MMP-2). Furthermore, we demonstrate that the increase in MMP-2 activation is largely caused by increased expression of membrane type-1 (MT1)-MMP expression, the primary MMP-2 activator. Finally, treatment with MMP-2 inhibitors resulted in increased HCSM cell viability in the presence of pathogenic A beta. Our findings suggest that increased expression and activation of MMP-2 may contribute to HCSM cell death in response to pathogenic A beta. In addition, these activities may also contribute to loss of vessel wall integrity in CAA resulting in hemorrhagic stroke. Therefore, further understanding into the role of MMPs in HCSM cell degeneration may facilitate designing therapeutic strategies to treat CAA found in AD and related disorders.
12753080	11	17	A beta	Gene	351
12753080	59	85	matrix metalloproteinase-2	Gene	4313
12753080	89	94	human	Species	9606
12753080	132	159	Cerebral amyloid angiopathy	Disease	MESH:D016657
12753080	161	164	CAA	Disease	MESH:D016657
12753080	201	220	Alzheimer's disease	Disease	MESH:D000544
12753080	244	249	Human	Species	9606
12753080	281	285	HCSM	CellLine	CVCL:F640
12753080	331	334	CAA	Disease	MESH:D016657
12753080	445	451	A beta	Gene	351
12753080	504	510	A beta	Gene	351
12753080	550	554	HCSM	CellLine	CVCL:F640
12753080	634	640	A beta	Gene	351
12753080	707	713	A beta	Gene	351
12753080	758	784	matrix metalloproteinase-2	Gene	4313
12753080	786	791	MMP-2	Gene	4313
12753080	843	848	MMP-2	Gene	4313
12753080	905	930	membrane type-1 (MT1)-MMP	Gene	4323
12753080	955	960	MMP-2	Gene	4313
12753080	996	1001	MMP-2	Gene	4313
12753080	1035	1039	HCSM	CellLine	CVCL:F640
12753080	1085	1091	A beta	Gene	351
12753080	1158	1163	MMP-2	Gene	4313
12753080	1182	1186	HCSM	CellLine	CVCL:F640
12753080	1224	1230	A beta	Gene	351
12753080	1318	1321	CAA	Disease	MESH:D016657
12753080	1335	1353	hemorrhagic stroke	Disease	MESH:D000083302
12753080	1413	1417	HCSM	CellLine	CVCL:F640
12753080	1493	1496	CAA	Disease	MESH:D016657
12753080	1506	1508	AD	Disease	MESH:D000544
12753080	Association	MESH:D016657	351
12753080	Association	MESH:D000083302	4313
12753080	Positive_Correlation	4313	4323
12753080	Association	MESH:D016657	4313
12753080	Association	MESH:D000083302	351
12753080	Positive_Correlation	351	4313

